ORION PHARMA A/S: Financial statements 2022
CVR: 20601116
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 214,174,882 and a net result of DKK 7,529,338 compared with DKK 4,513,431 the year before. That is an increase of 0.8% compared with the year before. The profit margin was 3.5%. Equity in the 2022 report amounted to DKK 50,453,036. The solvency ratio was 60.7%. The company had 16 employees in the financial year.
- Revenue
- DKK 214,174,882
- Gross Profit
- DKK 24,926,000
- Profit/Loss
- DKK 7,529,338
- Equity
- DKK 50,453,036
- Total Assets
- DKK 83,089,725
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 214.2 mio. | 24.9 mio. | 7.5 mio. | 50.5 mio. | 16 |
| 2021 | 212.5 mio. | 20.7 mio. | 4.5 mio. | 47.9 mio. | 17 |
| 2020 | 282.9 mio. | 25.5 mio. | 6.3 mio. | 51.4 mio. | 20 |
| 2019 | 280.9 mio. | 43 mio. | 16.9 mio. | 57.6 mio. | 24 |
| 2018 | 247.1 mio. | 51 mio. | 20.5 mio. | 50.7 mio. | 28 |
Official annual report
Keep an eye on ORION PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ORION PHARMA A/S has published its annual report for 2021. Revenue came to DKK 212,530,416, and the net result was DKK 4,513,431.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.